Amphastar Pharmaceuticals (AMPH) Goodwill & Intangibles (2016 - 2026)

Amphastar Pharmaceuticals has reported Goodwill & Intangibles over the past 13 years, most recently at $566.0 million for Q4 2025.

  • For Q4 2025, Goodwill & Intangibles fell 9.96% year-over-year to $566.0 million; the TTM value through Dec 2025 reached $566.0 million, down 9.96%, while the annual FY2025 figure was $566.0 million, 9.96% down from the prior year.
  • Goodwill & Intangibles for Q4 2025 was $566.0 million at Amphastar Pharmaceuticals, down from $628.9 million in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $635.2 million in Q2 2023 and troughed at $37.0 million in Q3 2022.
  • A 5-year average of $355.7 million and a median of $575.2 million in 2025 define the central range for Goodwill & Intangibles.
  • Biggest five-year swings in Goodwill & Intangibles: fell 17.79% in 2022 and later soared 1614.89% in 2023.
  • Year by year, Goodwill & Intangibles stood at $45.0 million in 2021, then fell by 2.6% to $43.8 million in 2022, then soared by 1329.79% to $626.8 million in 2023, then grew by 0.29% to $628.6 million in 2024, then dropped by 9.96% to $566.0 million in 2025.
  • Business Quant data shows Goodwill & Intangibles for AMPH at $566.0 million in Q4 2025, $628.9 million in Q3 2025, and $628.9 million in Q2 2025.